TG Therapeutics | TGTX - Cost Of Sales

Stock Price
30.35
Daily Change
-0.55 -1.78%
Monthly
0.13%
Yearly
0.86%
Q1 Forecast
28.61

TG Therapeutics reported $38.14M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Amgen USD 1.79B 128M Dec/2025
Ardelyx USD 3.98M 10.84M Sep/2025
Bayer EUR 4.31B 57M Sep/2025
Biogen USD 810.1M 205.1M Sep/2025
Corcept Therapeutics USD 2.54M 2.05M Dec/2025
Curis USD 10.27M 610K Jun/2024
Gilead Sciences USD 1.62B 50M Dec/2025
Infinity Pharmaceuticals USD 352K 89K Jun/2023
J&J USD 7.97B 689M Dec/2025
Karyopharm Therapeutics USD 37.43M 2.41M Sep/2024
Novartis USD 3.54B 217M Sep/2025
Novavax USD 60.62M 91.77M Sep/2024
PTC Therapeutics USD 16.3M 7.02M Dec/2025
Puma Biotechnology USD 29.1M 18.44M Sep/2024
Regeneron Pharmaceuticals USD 584.6M 63M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
TG Therapeutics USD 38.14M 10.05M Dec/2025
Verastem USD 0 0 Dec/2021
Vertex Pharmaceuticals USD 466M 51.2M Dec/2025